價(jià)格 | ¥1280 | ¥1980 | ¥2900 |
包裝 | 50ul | 100ul | 200ul |
最小起訂量 | 50ul |
發(fā)貨地 | 上海 |
文件下載 | 檢測(cè)報(bào)告COA |
更新日期 | 2025-01-08 |
中文名稱:Anti-Phospho-Bcl-2-磷酸化Bcl-2抗體 | 英文名稱:Phospho-Bcl-2 (Thr129) |
品牌: 滬震生物 | 產(chǎn)地: 中國/上海 |
保存條件: -20°C | 純度規(guī)格: > 99% |
產(chǎn)品類別: 抗體 一抗 | |
抗體名: Bcl-2 (phospho T129); Bcl-2 (phospho Thr129); p-Bcl-2 (Thr129); Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN. | 靶點(diǎn): 詳見說明書 |
宿主: Rabbit | 適應(yīng)物種: 詳見說明書 |
克隆性: 詳見說明書 | 濃度: 1mg/ml |
應(yīng)用范圍: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. | 標(biāo)識(shí)物: 詳見說明書 |
形態(tài): 液體 | 亞型: IgG1 |
免疫原: 詳見說明書 | 貨號(hào): HZ-R5220 |
用途范圍: 科研使用 | 規(guī)格: 50ul/100ul/200ul |
是否進(jìn)口: 否 | 是否單克隆: 詳見說明書 |
保質(zhì)期: 12個(gè)月 | 抗原來源: 詳見說明書 |
標(biāo)記物: 詳見說明書 | 產(chǎn)品用途: WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 (石蠟切片需做抗原修復(fù)) not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
Host:Rabbit
Target Protein:Phospho-Bcl-2 (Thr129)
IR:Immunogen Range:FA(p-T)VV
Clonality:Polyclonal
Isotype:IgG
Entrez Gene:596
Swiss Prot:P49950
Source:KLH conjugated Synthesised phosphopeptide derived from human Bcl-2 around the phosphorylation site of Thr129:FA(p-T)VV
Purification:affinity purified by Protein A
Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Background:BCL2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1). It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, and is necessary for anti-apoptotic activity.
Size:50ul
Concentration:1mg/ml
Applications:WB(1:500-2000)
ELISA(1:5000-10000)
IHC-P(1:100-500)
IHC-F(1:100-500)
Flow-Cyt(1μg/Test)
IF(1:100-500)
Cross Reactive Species:Human
Mouse
Rat
Dog
Pig
Cow
Horse
Sheep
.
本產(chǎn)品僅供科研使用。不能用于人和動(dòng)物治療等其它臨床診斷使用!
成立日期 | 2014-05-08 (11年) | 注冊(cè)資本 | 100萬元整 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,細(xì)胞培養(yǎng),蛋白組學(xué),分子生物學(xué),細(xì)胞生物學(xué) | 經(jīng)營模式 | 工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
碧云天生物技術(shù)有限公司
|
2024-12-25 | ||
詢價(jià) |
安諾倫(北京)生物科技有限公司
|
2024-12-25 | ||
¥1380 |
VIP4年
|
上海雅吉生物科技有限公司
|
2025-01-09 |